
Nvidia China Ban; Baidu Jumps; Eli Lilly Lower
Stock Movers
00:00
Stock Movements: Eli Lilly vs. Novo Nordisk in Weight Loss Market
This chapter examines the recent stock price changes of Eli Lilly and Novo Nordisk, focusing on Eli Lilly's decline in analyst favor and Novo Nordisk's growth outlook due to its promising drug pipeline. The discussion includes broader market implications and comparative performance insights between the two pharmaceutical giants.
Transcript
Play full episode